See more : Yao Sheng Electronic Co., Ltd. (3207.TWO) Income Statement Analysis – Financial Results
Complete financial analysis of iAnthus Capital Holdings, Inc. (IAN.CN) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of iAnthus Capital Holdings, Inc., a leading company in the Drug Manufacturers – Specialty & Generic industry within the Healthcare sector.
- Coastal Greenland Limited (1124.HK) Income Statement Analysis – Financial Results
- PJP Makrum S.A. (PJP.WA) Income Statement Analysis – Financial Results
- Sabuy Connext Tech Public Company Limited (SBNEXT.BK) Income Statement Analysis – Financial Results
- Plutus PowerGen Plc (PPG.L) Income Statement Analysis – Financial Results
- AB Sagax (publ) (EFE.F) Income Statement Analysis – Financial Results
iAnthus Capital Holdings, Inc. (IAN.CN)
Industry: Drug Manufacturers - Specialty & Generic
Sector: Healthcare
Website: https://www.ianthus.com
About iAnthus Capital Holdings, Inc.
iAnthus Capital Holdings, Inc. owns and operates licensed cannabis cultivation, processing, and dispensary facilities in the United States. It offers biomass products, such as pre-rolls; cannabis infused products, including topical creams and edibles; vape cartridges, concentrates, live resins, wax products, oils, and tinctures; cannabidiol products, such as topical creams, tinctures, and sprays, as well as products for beauty and skincare that include lotions, creams, haircare products, lip balms, and bath bombs. The company engages in the wholesale-distribution and retail of CBD products. It owns and/or operates 32 dispensaries and 10 cultivation and/or processing facilities in 8 states. The company was founded in 2014 and is headquartered in New York, New York.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 159.24M | 163.21M | 203.02M | 151.67M | 78.38M | 3.41M | 2.41M | 391.65K | 45.57K | 0.00 |
| Cost of Revenue | 96.07M | 88.78M | 91.74M | 64.99M | 38.52M | -6.19M | 0.00 | 0.00 | 0.00 | 0.00 |
| Gross Profit | 63.17M | 74.43M | 111.28M | 86.68M | 39.87M | 9.59M | 2.41M | 391.65K | 45.57K | 0.00 |
| Gross Profit Ratio | 39.67% | 45.60% | 54.81% | 57.15% | 50.86% | 281.68% | 100.00% | 100.00% | 100.00% | 0.00% |
| Research & Development | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 60.38M | 107.59M | 90.32M | 0.00 | 90.82M | 35.52M | 9.81M | 4.02M | 1.36M | 998.17K |
| Selling & Marketing | 4.35M | 4.80M | 4.54M | 0.00 | 5.14M | 0.00 | 0.00 | 0.00 | 0.00 | 5.12K |
| SG&A | 64.73M | 112.39M | 96.97M | 109.04M | 90.82M | 35.52M | 9.81M | 4.02M | 1.36M | 1.56M |
| Other Expenses | 39.15M | 32.26M | 30.52M | 29.30M | 23.63M | -65.28K | -17.63K | -200.81K | 0.00 | 0.00 |
| Operating Expenses | 103.88M | 144.65M | 127.48M | 138.33M | 114.45M | 41.87M | 9.96M | 4.03M | 1.36M | 1.56M |
| Cost & Expenses | 199.95M | 233.43M | 219.22M | 203.32M | 152.97M | 35.69M | 9.96M | 4.03M | 1.36M | 1.56M |
| Interest Income | 1.85M | 86.00K | 517.00K | 403.00K | 23.90M | 566.87K | 1.98M | 306.47K | 21.22K | 0.00 |
| Interest Expense | 30.16M | 22.25M | 32.67M | 37.65M | 25.25M | 20.93M | 2.49M | 290.82K | 0.00 | 0.00 |
| Depreciation & Amortization | 27.17M | 31.39M | 31.04M | 27.92M | 23.63M | 6.35M | 144.19K | 7.74K | 1.32M | 1.56M |
| EBITDA | -2.59M | -25.02M | 7.96M | -22.50M | -267.16M | -25.30M | -7.62M | -4.50M | 0.00 | -1.06K |
| EBITDA Ratio | -1.63% | -15.33% | 8.34% | -14.84% | -64.90% | -742.86% | -316.51% | -1,149.35% | -2,887.57% | 0.00% |
| Operating Income | -40.71M | -70.22M | -14.11M | -51.65M | -74.50M | -32.28M | -7.55M | -3.64M | -1.32M | -1.56M |
| Operating Income Ratio | -25.57% | -43.02% | -6.95% | -34.06% | -95.05% | -947.97% | -313.62% | -928.56% | -2,887.57% | 0.00% |
| Total Other Income/Expenses | -19.21M | -326.25M | -31.97M | -44.84M | 12.34M | -24.44M | -4.04M | -1.42M | 0.00 | -1.06K |
| Income Before Tax | -59.92M | -438.70M | -54.00M | -290.07M | -304.28M | -62.03M | -13.72M | -5.06M | -1.32M | -1.56M |
| Income Before Tax Ratio | -37.63% | -268.79% | -26.60% | -191.25% | -388.20% | -1,821.51% | -569.81% | -1,290.87% | -2,887.57% | 0.00% |
| Income Tax Expense | 16.70M | 10.69M | 22.25M | 19.96M | -3.03M | -8.81M | 2.27M | 326.94K | -1.32M | -1.06K |
| Net Income | -76.62M | -449.39M | -76.25M | -310.03M | -301.25M | -62.03M | -13.72M | -5.06M | -1.32M | -1.56M |
| Net Income Ratio | -48.12% | -275.34% | -37.56% | -204.41% | -384.34% | -1,821.51% | -569.81% | -1,290.87% | -2,887.57% | 0.00% |
| EPS | -0.01 | -0.13 | -0.44 | -1.81 | -1.90 | -0.97 | -0.48 | -0.32 | -0.08 | -0.16 |
| EPS Diluted | -0.01 | -0.13 | -0.44 | -1.81 | -1.90 | -0.97 | -0.48 | -0.32 | -0.08 | -0.16 |
| Weighted Avg Shares Out | 6.44B | 3.37B | 171.72M | 171.65M | 158.21M | 63.86M | 28.58M | 15.80M | 16.95M | 9.78M |
| Weighted Avg Shares Out (Dil) | 6.44B | 3.37B | 171.72M | 171.65M | 158.21M | 63.86M | 28.61M | 15.98M | 16.95M | 10.00M |
Source: https://incomestatements.info
Category: Stock Reports